Asia-Pacific Secondary Hyperoxaluria Drug Market Analysis, Demand & Growth Forecast

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PIPELINE ANALYSIS

5 REGULATORY SCENARIO OF ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET

5.1 REGULATORY FRAMEWORK FOR PROBIOTICS

5.2 REGULATORY FRAMEWORK FOR EUROPE

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TARGETED TREATMENT FOR SECONDARY HYPEROXALURIA IS IN HIGH DEMAND

6.1.2 R&D INVESTMENT IN COMPANIES FOCUSING ON DRUG DEVELOPEMENT

6.1.3 LOW DIETARY AWARENESS IN UPPER SOCIO-ECONOMIC SOCIETY

6.1.4 INCREASED NUMBER OF CASES FOR SECONDARY HYPEROXALURIA

6.1.5 LOSS OF OXALOBACTER FORMIGENES

6.2 RESTRAINTS

6.2.1 LIMITED OPERATING REVENUE

6.2.2 HIGH COST OF TREATING SECONDARY HYPEROXALURIA

6.2.3 LIMITED SECONDARY THERAPEUTICS OPTION FOR TREATMENT

6.3 OPPORTUNITIES

6.3.1 DIFFICULTY IN MAINTAINING LOW OXALATE DIET

6.3.2 INCREASING NUMBER OF BARIATRIC SURGERY

6.3.3 REGULATORY SUPPORT FOR APPROVAL

6.3.4 RISING DISPOSABLE INCOME

6.4 CHALLENGES

6.4.1 DELAY IN DIAGNOSIS OF DISEASE LEADING TO NEED FOR RENAL REPLACEMENT

6.4.2 INCREASE FITNESS AWARENESS AMONG PEOPLE

6.4.3 INCREASE FLUID INTAKE AS A PREVENTIVE MEASURES

7 COVID-19 IMPACT ON ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET

7.1 OVERVIEW

7.2 PRICE IMPACT

7.3 IMPACT ON DEMAND

7.4 IMPACT ON SUPPLY CHAIN

7.5 STRATEGIC DECISIONS FOR MANUFACTURERS

7.6 CONCLUSION

8 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE

8.1 OVERVIEW

8.2 SUPPLEMENTS

8.2.1 OXALATE BINDING AGENTS

8.2.1.1 CALCIUM SUPPLEMENTS

8.2.1.2 MAGNESIUM SUPPLEMENTS

8.2.1.3 OTHERS

8.2.2 CITRATE SUPPLEMENTS

8.2.3 PYRIDOXINE SUPPLEMENTS

8.2.4 PROBIOTICS

8.3 THIAZIDE DIURETICS

8.4 RELOXALIASE

9 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE

9.1 OVERVIEW

9.2 OVER THE COUNTER

9.3 PRESCRIPTION

10 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE

10.1 OVERVIEW

10.2 ADULTS

10.3 CHILDREN

11 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER

11.1 OVERVIEW

11.2 HOME HEALTHCARE

11.3 HOSPITALS

11.4 SPECIALTY CLINICS

11.5 OTHERS

12 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 RETAIL PHARMACIES

12.3 HOSPITAL PHARMACIES

12.4 ONLINE PHARMACIES

12.5 OTHERS

13 ASIA-PACIFIC SECONDARY HYPEROXLURIA DRUG MARKET, BY GEOGRAPHY

13.1 ASIA-PACIFIC

13.1.1 CHINA

13.1.2 JAPAN

13.1.3 INDIA

13.1.4 AUSTRALIA

13.1.5 SOUTH KOREA

13.1.6 SINGAPORE

13.1.7 THAILAND

13.1.8 MALAYSIA

13.1.9 INDONESIA

13.1.10 PHILIPPINES

13.1.11 VIETNAM

13.1.12 REST OF ASIA-PACIFIC

14 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

15 COMPANY PROFILE

15.1 NESTLE

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 GLAXOSMITHKLINE PLC

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 BAYER AG

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENTS

15.4 NOW FOODS

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 SOLGAR INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENT

15.6 PHARMAVITE

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 INFINITUS (CHINA)

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENTS

15.8 MISSION PHARMACAL COMPANY

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 .RECENT DEVELOPMENT

15.9 OYSTER SHELL

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 ALLENA PHARMACEUTICALS, INC.

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 AMWAY CORP.

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 CELEBRATE VITAMINS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 ENTRING, LLC

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 NATURE’S BOUNTY

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 OXTHERA

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 RENEW LIFE FORMULAS, INC.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 SYNLOGIC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENTS

15.18 TIENS

15.18.1 COMPANY SNAPSHOT

15.18.2 PRODUCT PORTFOLIO

15.18.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

LIST OF TABLES

TABLE 1 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, PIPELINE ANALYSIS

TABLE 2 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 3 ASIA-PACIFIC SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC OXALATE BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC THIAZIDE DIURETICS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC RELOXALIASE IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC OVER THE COUNTER IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC PRESCRIPTION IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC ADULTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC CHILDREN IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC HOME HEALTHCARE IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC HOSPITALS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC SPECIALTY CLINICS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC OTHERS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC RETAIL PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC HOSPITAL PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC ONLINE PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC OTHERS PHARMACIES IN SECONDARY HYPEROXALURIA DRUG MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 32 CHINA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 33 CHINA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 34 CHINA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 35 CHINA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 36 CHINA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 37 CHINA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 CHINA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 39 JAPAN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 40 JAPAN SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 41 JAPAN OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 JAPAN SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 43 JAPAN SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 44 JAPAN SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 JAPAN SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 INDIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 INDIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 48 INDIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 49 INDIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 50 INDIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 51 INDIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 52 INDIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 53 AUSTRALIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 54 AUSTRALIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 AUSTRALIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 AUSTRALIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 57 AUSTRALIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 58 AUSTRALIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 59 AUSTRALIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 60 SOUTH KOREA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 61 SOUTH KOREA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 62 SOUTH KOREA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 63 SOUTH KOREA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 64 SOUTH KOREA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 65 SOUTH KOREA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 SOUTH KOREA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 SINGAPORE SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 SINGAPORE SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 SINGAPORE OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 SINGAPORE SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 71 SINGAPORE SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 72 SINGAPORE SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 SINGAPORE SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 THAILAND SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 75 THAILAND SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 76 THAILAND OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 77 THAILAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 78 THAILAND SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 79 THAILAND SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 80 THAILAND SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 81 MALAYSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 MALAYSIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 83 MALAYSIA OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 MALAYSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 85 MALAYSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 86 MALAYSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 MALAYSIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 INDONESIA SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 89 INDONESIA SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 90 SWITZRLAND OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 INDONESIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 92 INDONESIA SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 93 INDONESIA SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 94 INDONESIA SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 95 PHILIPPINES SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 96 PHILIPPINES SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 97 PHILIPPINES OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 98 PHILIPPINES SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 99 PHILIPPINES SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 100 PHILIPPINES SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 101 PHILIPPINES SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 102 VIETNAM SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 VIETNAM SUPPLEMENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 VIETNAM OXALATE-BINDING AGENTS IN SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 VIETNAM SECONDARY HYPEROXALURIA DRUG MARKET, BY DRUG TYPE, 2019-2028 (USD MILLION)

TABLE 106 VIETNAM SECONDARY HYPEROXALURIA DRUG MARKET, BY POPULATION TYPE, 2019-2028 (USD MILLION)

TABLE 107 VIETNAM SECONDARY HYPEROXALURIA DRUG MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 VIETNAM SECONDARY HYPEROXALURIA DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 109 REST OF ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET, BY TYPE, 2019-2028 (USD MILLION)

List of Figure

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: SEGMENTATION

FIGURE 12 LOW DIETARY AWARENESS IN UPPER SOCIO-ECONOMIC SOCIETY IS EXPECTED TO DRIVE THE ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 SUPPLEMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET IN 2021 & 2028

FIGURE 14 REGULATORY FRAMEWORK FOR PROBIOTICS

FIGURE 15 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGE OF ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET

FIGURE 16 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2020

FIGURE 17 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 18 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 19 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, 2020

FIGURE 21 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUGS CLASS, 2020-2028 (USD MILLION)

FIGURE 22 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, CAGR (2021-2028)

FIGURE 23 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, 2020

FIGURE 25 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)

FIGURE 26 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, CAGR (2021-2028)

FIGURE 27 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, 2020

FIGURE 29 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 30 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, CAGR (2021-2028)

FIGURE 31 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY END USER, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 33 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 34 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 35 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: SNAPSHOT (2020)

FIGURE 37 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2020)

FIGURE 38 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2021 & 2028)

FIGURE 39 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: BY TYPE (2021-2028)

FIGURE 41 ASIA-PACIFIC SECONDARY HYPEROXALURIA DRUG MARKET: COMPANY SHARE 2020 (%)